Neogenomics OverviewNeogenomics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for NEO.
Quarterly EBIT
-$16.98M
↑ 29.36% YoY
As of Mar 31, 2026
Annual EBIT (TTM)
-$95.68M
↑ 2.49% YoY
Trailing 12 months ending Mar 31, 2026
Neogenomics OverviewEBIT (Earnings Before Interest and Taxes) analysis for NEO.
As of Mar 31, 2026
Trailing 12 months ending Mar 31, 2026